EORTC protocol 30901

A RANDOMIZED PHASE III TO COMPARE TUR AND YAG-LASER FOLLOWED BY INTRAVESICAL CHEMOPROPHYLAXIS WITH Epirubicin in SINGLE RECURRENT, MULTIPLE PRIMARY OR RECURRENT Ta-T1 TCC OF THE BLADDER
Trial StatusAll trial activities ended
DatesDate of activation: 15-Oct-90
Closed on : 17-Oct-91
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size304
Number of steps1
Drug
Study StaffRoland Van Velthoven (Study Coordinator) - Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet, Brussels
Type of cancerBladder
Participating GroupsEORTC Genito-Urinary Cancers Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section